Rebecca Zorn Sells Shares of Globe Life Inc.
Globe Life's EVP & Chief Talent Officer, Rebecca Zorn, sold 2,000 shares.
Key Points
- On June 18, 2026, Rebecca Zorn, EVP & Chief Talent Officer at Globe Life Inc., sold 2,000 shares valued at $340,200.
- Globe Life Inc. trades on the NYSE with a market cap of $13.3 billion and a P/E ratio of 11.82.
- Analysts maintain a positive outlook on Globe Life with multiple 'buy' ratings and a target mean price of $175.91.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 18, 2026, Rebecca Zorn, the Executive Vice President and Chief Talent Officer at Globe Life Inc., sold 2,000 shares of the company. The shares were sold at an average price of $170.10, totaling $340,200. This transaction was not part of a pre-arranged trading plan.
Insider Buying and Selling at Globe Life Inc.
Rebecca Zorn's recent sale of 2,000 shares at $170.10 per share is part of her activity as Globe Life's EVP & Chief Talent Officer. This transaction followed her previous purchase of 2,000 shares at $98.32 earlier in the year. Other notable insider transactions include Robert Brian Mitchell, EVP, General Counsel and CRO, selling 1,250 shares, and Dolores Skarjune, EVP and Chief Admin. Officer, selling 4,175 shares at $166.18.
Globe Life Inc. Stock Down 0.4%
Shares of NYSE:GL traded near $170.76 on Monday. Globe Life Inc. has a market cap of approximately $13.3 billion and a P/E ratio of 11.82. The stock's 52-week range is between $116.73 and $172.74, with a 50-day moving average of $154.99 and a 200-day moving average of $143.00. The company's beta is 0.499, indicating lower volatility compared to the market.
$GL stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
Analysts have maintained a positive outlook on Globe Life Inc. Piper Sandler, Morgan Stanley, and Truist Securities all maintained their 'buy' ratings, with target prices of $175, $181, and $185, respectively. The consensus among analysts is a 'buy' rating, with a target mean price of $175.91 based on 11 opinions.
About Globe Life Inc.
Globe Life Inc. provides life and supplemental health insurance products primarily to lower middle- and middle-income families in the United States. The company operates through its Life Insurance, Supplemental Health Insurance, and Investments segments. Headquartered in McKinney, Texas, Globe Life is led by CEO Frank Martin Svoboda and employs around 3,695 people. The company was formerly known as Torchmark Corporation before changing its name in 2019.
Bottom Line
Rebecca Zorn's recent sale of shares in Globe Life Inc. is a notable insider transaction. Investors often track such insider activities for potential insights into company performance. It's important to remember that insider transactions can have various motivations and do not necessarily indicate a positive or negative outlook. Globe Life remains a focus for analysts, with a strong 'buy' consensus and favorable price targets.
Get Globe Life Inc. alerts
New 13F filings, insider trades, and analyst moves on $GL, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.